Atlas Trials

Study To Evaluate The Efficacy And Safety Of Oral PF-06651600 And PF-06700841 In Subjects With Moderate To Severe Crohn's Disease

Clinical trial NCT03395184 · COMPLETED

Trial details

NCT number
NCT03395184
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Crohn's Disease
Start date
2018-02-02
Primary completion
2023-10-19
Enrollment
244

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.